The effect of thio-TEPA on developing and established mammalian bladder tumors
- 1 March 1980
Abstract
The inhibitory effect of thio-TEPA on both developing and established mammalian bladder cancer was tested in the FANFT model system using female C3H/He mice. This model allows the histologic evaluation of the entire target organ, a major advantage over clinical trials, which have relied largely on endoscopic appearance for determination of response. A powerful carcinogen, FANFT is known to cause bladder carcinoma in at least 90% of these animals within 12 months. The tumors develop through a spectrum of morphologic changes including hyperplasia, dysplasia, and carcinoma in situ. Animals were divided into equally sized control and test groups and either thio-TEPA or saline was administered on a schedule designed to correspond to that used in clinical trials. Bladders from 159 mice were evaluated grossly, microscopically and in some instances, ultrastructurally, for the presence of tumor or other intraepithelial lesions. When compared to controls, thio-TEPA had no statistically significant inhibitory effect on either developing or established bladder tumors. The drug did, however, cause a statistically significant decrease in the frequency of high-grade, high-stage lesions when given during tumor development and may retard the evolution of such neoplasms from low-grade noninvasive carcinomas. The correlation of these experimental findings with the reportedly beneficial results of clinical trials is discussed.This publication has 21 references indexed in Scilit:
- Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancerUrology, 1977
- Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: Further studies of surgically removed bladders by mappingUrology, 1977
- Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in SituJournal of Urology, 1976
- Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBritish Journal of Urology, 1976
- Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of ratsZeitschrift für Krebsforschung und Klinische Onkologie, 1976
- The Effects of Topical Thiotepa on the Recurrence Rate of Superficial Bladder CancersJournal of Urology, 1968
- Control of Bladder Tumors by Endoscopic SurgeryJournal of Urology, 1967
- THIOTEPA IN THE TREATMENT OF TUMOURS OF THE BLADDERThe Lancet, 1961
- Bladder Tumors and Associated Proliferative Mucosal LesionsJournal of Urology, 1960
- Histological Study of Vesical Urothelium Intervening Between Gross Neoplasms in Total CystectomyJournal of Urology, 1952